PRIME CAPITAL CORP
NT 10-K, 1995-03-31
MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES
Previous: PENNROCK FINANCIAL SERVICES CORP, DEF 14A, 1995-03-31
Next: CHRYSLER CORP /DE, DEF 14A, 1995-03-31



                U.S. SECURITIES AND EXCHANGE COMMISSION
                        WASHINGTON, D.C. 20549


                                 FORM 12b-25

                                              SEC File Number:0-14888
                                              CUSIP Number: 741910103

                        NOTIFICATION OF LATE FILING

                               (Check One):

(x) Form 10-KSB (  ) Form 11-K  (  )Form 20-F  ( )Form 10-Q (  ) Form N-SAR

                  For Period Ended:    December 31, 1994
                                                                              

     Nothing in this Form shall be construed to imply that the Commission
     has verified any information contained herein.
                                                                              

  If the notification relates to a portion of the filing checked above,
   identify the Item(s) to which the notification relates:         N/A     
                                                                              

PART I -- REGISTRANT INFORMATION
                                                                              

  Full Name of Registrant:  Prime Capital Corporation

  Former Name if Applicable:            N/A          
                                                                              
  Address of Principal Executive Office (Street and Number):

        10275 West Higgins Road, Suite 200                                    
  City, State and Zip Code:

        Rosemont, Illinois  60018                                             

PART II--RULES 12b-25 (b) AND (c)
                                                                              

  If the subject report could not be filed without unreasonable effort or
  expense and the registrant seeks  relief pursuant to Rule 12b-25(b), the
  following should be completed.  (Check box if appropriate):

  (X)  (a) The reasons described in reasonable detail in Part III of this
           form could not be eliminated without unreasonable effort or
           expense; and

  (X)  (b) The subject annual report or semi-annual report/portion thereof
           will be filed on or before the fifteenth calendar day following
           the prescribed due date; or the subject quarterly
           report/portion thereof will be filed on or before the fifth
           calendar day following the prescribed due date; and

  (  ) (c) The accountant's statement or other exhibit required by Rule
           12b-25(c) has been attached, if applicable.
<PAGE>
                                                                              
PART III--NARRATIVE
                                                                              

  State below in reasonable detail the reasons why the form 10-K, 11-K,
  20-F, 10-Q or N-SAR or portion thereof could not be filed within the
  prescribed time period:

  Information required to complete the Form 10-KSB is not available at
  this time.

                                                                              

PART IV--OTHER INFORMATION
                                                                              

  (1)  Name and telephone number of person to contact in regard to this
       notification:

       Gerald H. Allen                                    (708)  294-6000       
            (Name)                             (Area Code) (Telephone Number)

  (2)  Have all other periodic reports required under section 13 
       or 15(d) of the Securities Exchange Act of 1934 or Section
       30 of the Investment Company Act of 1940 during the 
       preceding 12 months (or for such shorter period that the 
       registrant was required to file such  reports) been filed?
       If the answer is no, identify report(s).        (X) Yes  ( ) No
           

  (3)  Is it anticipated that any significant change in results of
       operations from the corresponding period for the last fiscal 
       year will be reflected by the earnings statements  to be 
       included in the subject report or portion thereof?   (X) Yes  ( ) No

       If so, attach an explanation of the anticipated change, both
       narratively and quantitatively, and, if appropriate, state 
       the reasons why a reasonable estimate of the results can 
       not be made.

                         Prime Capital Corporation                            
               (Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.

Date:    March 31, 1995      By:/s/ Gerald H. Allen                            
                             Gerald H. Allen, Senior Vice President

INSTRUCTION:  The form may be signed by an executive officer of the
registrant or by any other duly authorized representative.  The name and
title of the person signing the form shall be typed or printed
beneath the signature.  If the statement is signed on behalf of the
registrant by an authorized representative
(other than an executive officer), evidence of the representative's
authority to sign on behalf of the registrant shall be filed with the form.
                                                                              
                             A T T E N T I O N

 Intentional misstatements or omissions of fact constitute Federal
  Criminal Violations (See 18 U.S.C. 1001).
                                                                              
<PAGE>
                         PRIME CAPITAL CORPORATION
                         ATTACHMENT TO FORM 12b-25
                  For Period Ended:    December 31, 1994


The Company expects that it will report a net loss for the year ended
December 31, 1994.  The Company estimates that the net loss will be
approximately ($1,990,000) or ($0.47) per share for the year ended
December 31, 1994 compared to net income of of approximately $2,000,000
or $0.47 per share for the same period in 1993.

                                                                            
<PAGE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission